X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with BAJAJ CORP - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BAJAJ CORP - Comparison Results

BAJAJ CORP 
   Change

Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BAJAJ CORP AMAR REMEDIES/
BAJAJ CORP
 
P/E (TTM) x -0.5 24.3 - View Chart
P/BV x 0.1 10.7 0.6% View Chart
Dividend Yield % 0.0 3.4 -  

Financials

 AMAR REMEDIES   BAJAJ CORP
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BAJAJ CORP
Mar-18
AMAR REMEDIES/
BAJAJ CORP
5-Yr Chart
Click to enlarge
High Rs164520 31.5%   
Low Rs86343 25.1%   
Sales per share (Unadj.) Rs261.656.2 465.8%  
Earnings per share (Unadj.) Rs17.414.3 121.5%  
Cash flow per share (Unadj.) Rs22.314.8 150.5%  
Dividends per share (Unadj.) Rs012.00 0.0%  
Dividend yield (eoy) %02.8 0.0%  
Book value per share (Unadj.) Rs100.733.4 301.7%  
Shares outstanding (eoy) m26.16147.50 17.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.7 6.2%   
Avg P/E ratio x7.230.1 23.8%  
P/CF ratio (eoy) x5.629.1 19.3%  
Price / Book Value ratio x1.212.9 9.6%  
Dividend payout %083.9 0.0%   
Avg Mkt Cap Rs m3,27063,609 5.1%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m163771 21.1%   
Avg. sales/employee Rs ThNM7,351.3-  
Avg. wages/employee Rs ThNM683.9-  
Avg. net profit/employee Rs ThNM1,872.9-  
INCOME DATA
Net Sales Rs m6,8448,285 82.6%  
Other income Rs m21244 8.6%   
Total revenues Rs m6,8658,529 80.5%   
Gross profit Rs m1,1312,539 44.5%  
Depreciation Rs m12874 173.4%   
Interest Rs m39812 3,235.8%   
Profit before tax Rs m6262,698 23.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121587 20.6%   
Profit after tax Rs m4552,111 21.6%  
Gross profit margin %16.530.6 53.9%  
Effective tax rate %19.321.7 88.9%   
Net profit margin %6.625.5 26.1%  
BALANCE SHEET DATA
Current assets Rs m4,9044,318 113.6%   
Current liabilities Rs m3,5811,143 313.3%   
Net working cap to sales %19.338.3 50.4%  
Current ratio x1.43.8 36.3%  
Inventory Days Days12421 604.7%  
Debtors Days Days10014 700.8%  
Net fixed assets Rs m1,6891,734 97.4%   
Share capital Rs m262148 177.6%   
"Free" reserves Rs m2,3584,777 49.4%   
Net worth Rs m2,6354,925 53.5%   
Long term debt Rs m5070-   
Total assets Rs m6,8626,075 113.0%  
Interest coverage x2.6220.3 1.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 73.1%   
Return on assets %12.434.9 35.6%  
Return on equity %17.342.9 40.3%  
Return on capital %31.055.0 56.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273157 174.3%   
Fx outflow Rs m225 8.2%   
Net fx Rs m271132 205.1%   
CASH FLOW
From Operations Rs m-3131,801 -17.4%  
From Investments Rs m-489368 -132.6%  
From Financial Activity Rs m769-2,156 -35.7%  
Net Cashflow Rs m-3313 -255.9%  

Share Holding

Indian Promoters % 25.5 66.9 38.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 1.6 564.4%  
FIIs % 0.0 24.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 7.1 919.7%  
Shareholders   13,061 19,219 68.0%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   KARUTURI GLOBAL  GILLETTE INDIA  GODREJ INDUSTRIES  GODREJ CONSUMER  RELAXO FOOTWEARS  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

BAJAJ CORP Announces Quarterly Results (2QFY19); Net Profit Up 1.8% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BAJAJ CORP has posted a net profit of Rs 516 m (up 1.8% YoY). Sales on the other hand came in at Rs 2 bn (up 4.2% YoY). Read on for a complete analysis of BAJAJ CORP's quarterly results.

BAJAJ CORP 2017-18 Annual Report Analysis (Annual Result Update)

Aug 21, 2018 | Updated on Aug 21, 2018

Here's an analysis of the annual report of BAJAJ CORP for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of BAJAJ CORP. Also includes updates on the valuation of BAJAJ CORP.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - LINC PEN & PLASTICS LTD COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS